Clinical Trials Logo

Filter by:
NCT ID: NCT00750880 Completed - Clinical trials for Rheumatoid Arthritis

An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.

Start date: September 2008
Phase: Phase 3
Study type: Interventional

This open-label, single arm study will investigate the safety, tolerability and efficacy of tocilizumab monotherapy, or combination therapy with non-biologic disease modifying antirheumatic drugs (DMARDs), in patients with severe active RA. Patients will receive tocilizumab 8mg/kg iv as a 60 minute infusion every 4 weeks for a total of 6 infusions. The anticipated time on study treatment is 3-12 months, and the target sample size is >500 individuals.

NCT ID: NCT00750425 Completed - Clinical trials for Advanced Solid Tumors

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

Start date: August 2008
Phase: Phase 1
Study type: Interventional

Phase I, open study to assess the effect of ketoconazole, a marketed drug, on the way the body handles the experimental drug cediranib, in patients with advanced cancer.

NCT ID: NCT00747968 Completed - Type 2 Diabetes Clinical Trials

The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET

Start date: February 2010
Phase: Phase 2/Phase 3
Study type: Interventional

30 type 2 diabetic patients will be PET-scanned twice ( half of the patients heart-PET, half of the patients CNS-PET) in random order with infusions of placebo or GLP-1-analogue during hyperglycemic clamp to uncover the metabolic effects of GLP-1-analogues in perspectives of intervention of macrovascular late diabetic pathology such as stroke and AMI. Earlier studies have revealed tendencies towards steady glucose metabolism in the CNS despite fluctuations in blood sugar when infusing native GLP-1.

NCT ID: NCT00746213 Completed - Chronic Pain Clinical Trials

Chronic Pain After Thoracotomy, an Incidence Study

Start date: July 2008
Phase: N/A
Study type: Observational

This is an investigation on the frequency of chronic pain after thoracotomy for lung cancer. Factors relating to the development of chronic pain are investigated. Questionnaire survey.

NCT ID: NCT00745654 Completed - Clinical trials for Lung Transplantation

Chronic Pain After Lung Transplantation, an Incidence Study

Start date: July 2008
Phase: N/A
Study type: Observational

This is an investigation on the frequency of chronic pain amongst recipients after lung transplantation. Factors relating to the development of chronic pain are investigated.

NCT ID: NCT00744874 Completed - Clinical trials for Paroxysmal Atrial Fibrillation

Ablation of the Pulmonary Veins for Paroxysmal Afib

MAP-PAF
Start date: October 2007
Phase: Phase 4
Study type: Interventional

The purpose of this trial was to investigate and confirm the safety, efficacy, and efficiency of the Ablation Frontiers® Cardiac Ablation System when used in the treatment of paroxysmal atrial fibrillation. (PAF)

NCT ID: NCT00744718 Completed - Ovarian Cancer Clinical Trials

Bevacizumab and Carboplatin for Patients With Ovarian Cancer

Start date: August 2008
Phase: Phase 2
Study type: Interventional

This is a phase II trial to investigate the effect of bevacizumab and carboplatin in patients with platin resistant ovarian cancer.

NCT ID: NCT00742976 Completed - Weight Gain Clinical Trials

Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients

Le-Na
Start date: June 2008
Phase: Phase 4
Study type: Interventional

Hypothesis: Changing type 2 patients treatment from Insulin Insulatard to Insulin Detemir will increase their excretion of sodium in the urine and thereby decrease their extracellular volume and body weight. 24 patients are divided into 2 groups and their insulin treatment is shifted while their body composition, sodium excretion, weight and extracellular volume is monitored.

NCT ID: NCT00742443 Completed - Cicatrix Clinical Trials

Juvista in Scar Revision Surgery of Disfiguring Scars

Revise
Start date: December 2008
Phase: Phase 3
Study type: Interventional

This trial is to determine whether Juvista can prevent scar formation or improve the appearance of scars following scar revision surgery. The trial will involve comparing Juvista to placebo.

NCT ID: NCT00739973 Completed - Hypertension Clinical Trials

Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension

Start date: September 2008
Phase: Phase 3
Study type: Interventional

Evaluate the efficacy (blood pressure lowering effect) and safety of aliskiren alone and in combination with amlodipine in patients with essential hypertension.